//=time() ?>
From the March issue: Type I interferon regulates a coordinated gene network to enhance cytotoxic T cell–mediated tumor killing in #BreastCancer. @UCSDCRCERA @ResearchUCSD @UCSanDiego https://t.co/u90APmGMIE
Epigenetic therapy can suppress premetastatic changes in the lung. @FranckHousseau @HopkinsMedicine @hopkinskimmel @bloombergkimmel #Metastasis #Cancer https://t.co/zHMgsXUAbN
From the February issue: Histone lysine methylation dynamics control #EGFR DNA copy number amplification @ThomasLClarke @WhetstineLab @FoxChaseCancer #Cancer #Epigenetics https://t.co/CWjdp6PPpR
From the February issue: In vivo epigenetic #CRISPR screen identifies Asf1a as an immunotherapeutic target in #Kras-mutant lung adenocarcinoma @nyulangone @nyuschoolofmed #LungCancer #immunotherapy https://t.co/cOCYGhz1Y9
#ResearchWatch Preleukemic cells can be eliminated in NPM1-mutant acute myeloid #leukemia models. @HannahUckelmann @DanaFarber #AML https://t.co/x7dlllqbk6